Regulate logo

  • Facebook
  • Twitter

Regulate menu

Supplying sodium valproate safely to women and girls

25 July 2019

All members of the pharmacy team should make sure they follow the MHRA’s Pregnancy Prevention Programme (PPP) for sodium valproate every time it is dispensed. 

We spoke to two women whose children were affected by exposure to sodium valproate during their pregnancies, to find out why it’s so important to make sure that women are made aware of the risks when dispensing sodium valproate.

See the previous Regulate article on dispensing sodium valproate safely
 

Related articles

29 July 2019
A pharmacy professional’s religion, personal values and beliefs can play an important part in their life and make a positive contribution to their work and the care they provide. However, in some...
25 July 2019
Online provision of pharmacy services is a rapidly expanding business model where pharmacy services can potentially be delivered over a larger geographic area. Services delivered in this way can...
25 July 2019
We are looking for three new council members – two registrants and one member of the public - to help us achieve our aims of protecting the public and upholding the standards of pharmacy services....
25 July 2019
We have joined forces with eight other healthcare regulators to stress the benefits and importance of good reflective practice among professionals in the healthcare sector.  The chief executives of...
30 May 2019
We are currently asking for views on proposed guidance for pharmacist prescribers to make sure they provide safe and effective care when prescribing. The proposed guidance incorporates information we...